Table 2 Global and regional results; all patients (n = 28)
Baseline | 6 months | ||||||
|---|---|---|---|---|---|---|---|
mBMC | controls | p-value 1 | mBMC | controls | p-value 2 | ||
Left ventricle N = 28 | EDV - ml | 175.1 ± 48.7 | 176.8 ± 52.8 | 0.932 | 174.9 ± 60.0 | 174.3 ± 62.3 | 0.828 |
ESV - ml | 91.2 ± 35.2 | 84.9 ± 41.0 | 0.668 | 87.6 ± 44.9 | 78.0 ± 42.3 | 0.674 | |
EF - % | 49.3 ± 9.5 | 54.1 ± 11.3 | 0.233 | 52.4 ± 11.9 | 57.9 ± 10.1 | 0.610 | |
LV mass - g | 168.6 ± 28.3 | 171.5 ± 42.1 | 0.831 | 162.4 ± 30.8 | 160.4 ± 41.1* | 0.379 | |
infarct mass - g | 38.6 ± 23.3 | 45.7 ± 29.5 | 0.484 | 37.6 ± 20.5 | 35.7 ± 20.4* | 0.034 | |
infarct percent - % | 22.1 ± 12.4 | 26.4 ± 14.8 | 0.410 | 22.2 ± 10.8 | 22.0 ± 11.0* | 0.026 | |
global strain - % | -11.1 ± 2.4 | -11.9 ± 3.4 | 0.512 | -11.1 ± 2.6 | -13.1 ± 2.4* | 0.027 | |
twist - ° | 11.3 ± 3.6 | 12.8 ± 5.4 | 0.365 | 12.6 ± 4.3 | 11.8 ± 3.7 | 0.411 | |
Infarct zone N = 27 | mass - g | 103.0 ± 39.6 | 103.9 ± 37.6 | 0.955 | 100.3 ± 39.9 | 96.2 ± 34.5* | 0.217 |
infarct mass - g | 38.6 ± 23.3 | 45.7 ± 29.5 | 0.484 | 37.6 ± 20.5 | 35.7 ± 20.4* | 0.034 | |
infarct percent - % | 34.4 ± 13.6 | 41.5 ± 17.7 | 0.242 | 34.3 ± 12.6 | 35.0 ± 11.6* | 0.084 | |
strain - % | -9.7 ± 3.4 | -9.3 ± 4.1 | 0.770 | -10.2 ± 3.3 | -11.8 ± 3.0* | 0.009 | |
Transmural infarct zone N = 13 | mass - g | 32.3 ± 22.6 | 35.0 ± 26.2 | 0.855 | 33.7 ± 21.4 | 33.6 ± 24.0 | 0.519 |
infarct mass - g | 29.0 ± 23.0 | 32.5 ± 25.2 | 0.804 | 26.6 ± 17.7 | 26.1 ± 19.5 | 0.468 | |
infarct percent - % | 86.8 ± 7.4 | 90.3 ± 6.1 | 0.377 | 77.6 ± 4.3* | 76.6 ± 11.4* | 0.401 | |
strain - % | -2.0 ± 1.5 | -6.6 ± 5.6 | 0.107 | -2.4 ± 1.4 | -8.6 ± 4.9 | 0.108 | |
Remote segments N = 27 | mass - g | 64.4 ± 22.1 | 66.5 ± 24.3 | 0.816 | 61.1 ± 22.8 | 63.2 ± 24.0 | 0.965 |
strain - % | -14.4 ± 2.4 | -14.9 ± 2.3 | 0.560 | -14.3 ± 3.3 | -15.6 ± 2.3 | 0.195 | |